Shivom - DNA bank and a new step in the treatment of rare diseases.

Shivom - DNA bank and a new step in the treatment of rare diseases.

Foreword

Greetings to everyone on my blog. Today I am doing an emergency review for a very unusual project. Why the emergency review?Because it was supposed, the project will conduct sales of the tokens until July, but they are moving so fast that they have already approached their hardcap. I will tell you about the Shivom project.

About the project

Shivom is a company that was founded one year ago. The founders are DR. AXEL SCHUMACHER, SALLY EAVES and GOURISH SINGLA. Offices of the start-up are located in Munich, London, Chandigarh and San Francisco.

Contact details:

United Kingdom sally@shivom.io
Germany axel@shivom.io
India gourish@shivom.io
USA henry@shivom.io

The company Shivom has the goal to build the largest genetic center and bring medicine to a new level of its development. Molecular genetics, namely, its section of genomics, is a little-studied science. Nowadays, many studies and experiments are conducted, but most projects lack funding, and the government of some countries, outside the European Union, doesn't even support scientists in this field. We live in the 21st century and I believe that medicine and science should have good funding to develop and benefit society. In addition, do not forget that now the first position is occupied by blockchain technology and all world business is gradually switching to this technology. Blockchain is a continuous series of blocks containing information. Copies of block chains are stored on a variety of different computers independent of each other. Shivom also decided to keep up with the times and be in a trend, so the project will be built on blockchain technology.

Mission of the project

The mission of the Shivom project is to create a DNA database using blockchain technology, which provides transparency and complete security for the company and project users.

Application area

Genomics is used in many branches, but special attention should be given to medicine. The possibility of obtaining genome data provided new perspectives for medical clinicians and researchers. Genome information is used in the treatment of many rare diseases. For example, various pathologies of the heart and cardiovascular system, cancer and various diseases associated with the human genetic code, such as premature aging of children, abnormal growth, and other unexplained diseases.

About the principles of the Shivom platform

The platform has a very simple registration on the site - it's as easy as registering a mailbox. Go to the site and go through the registration, then enter your data. Alpha version will look like this: https://shivom.io/product.html

The company will mail you a kit for a medical test. Saliva analysis is usually used.

Look at the detailed scheme of work with the project Shivom:

Platform Advantages

Data on DNA can be sold or "leased" to the interested organization;
Probably that the platform will be used by medical centers, research institutes, and various pharmaceutical companies;
Together with platform users and large medical institutions, the platform creates its own closed ecosystem that will move medicine forward.
Also, don't forget about investors, who will receive dividends from the growth of the OmiX, OMX token. I'm sure that such a project will bring an annual stable growth for the capital. After all, medicine - it's not only science but also a very profitable business.

Crowdsale

To implement such a large-scale and ambitious project, investments are required, so the platform launched its crowdsale using blockchain and the release of its OMX token. Buying a token makes it possible to become a participant in the project and invest in a future DNA bank.

ICO Details

Blockchain: ETH, ERC20
Total tokens: 3.000.000.000
Name: OmiX, OMX
33% of tokens are allocated to the ICO.

PRE-SALE:

Started on April 16 and will end on April 27
Minimum investment amount 1 ETH
Softcap: 20000 ETH (cofacting)
Hardcap: 75000 ETH
The main sales likely will not be. The project has already sold tokens for 32,000,000 USD. A little before the end of sales
You must register with WhiteList https://shivom.io/private-sale.html

Team

Advisers and consultants

Road map

Conclusion

I consider this project very promising for investment. It has a huge potential and it will very well affect the growth of the token in the future. But if you do not even think about money, and look at the invaluable benefits that the project will bring in the future, it is already worth participating in it. At least it's very nice to be a part of such a grandiose project. As you already understood, it remains to collect 3 000 000 USD and the sale of the tokens will be closed, so you should hurry if you want to participate in the project of the future of our medicine and science.

Additional information about the project

Website - https://shivom.io
Whitepaper - https://shivom.io/files/Whitepaper.pdf
Bitcointalk ANN Thread - https://bitcointalk.org/index.php?topic=3204563.0
Bitcointalk Bounty Thread - https://bitcointalk.org/index.php?topic=3183600.0
Telegram - https://t.me/projshivom
======================
unsenameBTT : HunterM
LINK unsername BTT : https://bitcointalk.org/index.php?action=profile;u=1303504
ETH : 0x53CdBC815f56c0F9BBC2ddEF4836fb3A53cF15e3